⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNDX News
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX
Form 8-K
sec.gov
SNDX
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
SNDX
Syndax Announces Participation in March Investor Conferences
globenewswire.com
SNDX
Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026
globenewswire.com
SNDX
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
globenewswire.com
INCY
SNDX
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit
globenewswire.com
SNDX
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
SNDX
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
SNDX